• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The analysis of transcription factor and ECM degradation enzyme associated with invasion of glioblastoma

Research Project

Project/Area Number 13470290
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionKanazawa University

Principal Investigator

YAMASHITA Junkoh  Kanazawa University, Department of Neurosurgery, Professor, 大学院・医学系研究科, 教授 (90026948)

Co-Investigator(Kenkyū-buntansha) NAKADA Mitsutoshi  Kanazawa University, Hospital, Instructor, 医学部附属病院, 助手 (20334774)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥14,000,000 (Direct Cost: ¥14,000,000)
Fiscal Year 2002: ¥4,300,000 (Direct Cost: ¥4,300,000)
Fiscal Year 2001: ¥9,700,000 (Direct Cost: ¥9,700,000)
Keywordsglioblastoma / invasion / MMP / testican / ECM / 湿潤
Research Abstract

Proteolytic extracellular matrix (ECM) degradation is a key step in glioblastoma invasion. Although various proteinases are involved in the process, members of matrix metalloproteinases (MMPs), especially MMP-2, may play a central role in the degradation. To exert its enzymatic activity, pro-MMP-2 requires proteolytic activation by membrane-type MMPs (MT-MMPs) such as MT1-MMP. In the present study, we have screened a human fetal cDNA library by expression cloning for the regulator of pro-MMP-2 processing mediated by MT1-MMP and isolated a cDNA whose product interfered with pro-MMP-2 activation. It encodes N-terminal 313 amino acids regions of testican 3, and thus it was named N-Tes. Expression of testican 1 and testican 3 but not testican 2 also inhibited pro-MMP-2 activation by MT1-MMP. Deletion and substitution of amino acids residues in N-Tes revealed that N-terminal 110 amino acid region of N-Tes is enough for the inhibition of pro-MMP-2 activation by MT1-MMP. In addition, we showe … More d that testican 2 inactivates N-Tes by binding to the C-terminal extracellular calcium-binding (EC) domain of N-Tes through its N-terminal unique domain. Migration of U251 cells on collagen was dependent on MT1-MMP activity and was inhibited by N-Tes or N-Tes deletion mutant lacking the EC domain (N-Tes-Δ122) deposited on collagen. Binding of testican 2 to N-Tes deposited on collagen allowed migration of cells expressing MT1-MMP. Unlike N-Tes, N-Tes-Δ122 did not bind to testican 2, and thus expression of testican 2 did not recover cell migration blocked by N-Tes-Δ122. In situ hybridization showed that neurons are major source of all testican family members in the normal brain. The quantitative reverse transcription-polyraerase chain reaction analysis demonstrated that all members of testican family are expressed predominantly in normal brain, and their expression levels decrease as tumor grade increases. The expression level of testican 2 was the highest among testican family members regardless of histological grade of astrocytic tumors. These results suggest that N-Tes and testican 1, 3, which are brain ECM, interfere with tumor invasion by inhibiting MT-MMPs and that abundant distribution of testican 2 may contribute to glioma invasion by inactivating other testican family members including N-Tes, which all inhibit MT-MMPs. We propose that N-Tes-Δ122, which is resistant to testican 2, may have potential novel function as a barrier against glioma invasion. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Nakada M: "The role of matrix metalloproteinase on glioma invasion"Frontiers in Bioscience. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M: "Suppression of membrane-type 1 matrix metalloproteinase(MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes"Cancer Research. 61. 8896-8902 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kita D: "Expression of dominant negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin α5 expression in U251 glioma cell line"Cancer Research. 61. 7985-7991 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M: "Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma"Journal of Neurosurgery. 94. 464-473 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Misaki K: "Contrast-enhanced fluid-attenuated inversion-recovery MRI is useful to detect the CSF dissemination of glioblastoma"Journal of Computer Assisted Tomography. 25. 953-956 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 中田光俊: "MT1-MMP制御分子;N-Tesの同定とグリオーマ浸潤抑制効果の解析"ポストシークエンス時代における脳腫瘍の研究と治療. 119-127 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M., Miyamori H., Yamashita J., Hiroshi Sato: "Testican 2 abrogates inhibition of membrane-type matrix metalloprotemases by other testican family proteins."Cancer Res. in submission

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M., Okada Y., Yamashita J.: "The role of matrix metalloproteinase on glioma invasion"Frontiers in Bioscience. in press

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M., Yamada A., Takino T., Miyamori H., Takahashi T., Yamashita J., Sato H.: "Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and t**or invasion by testican 3 and its splicing variant gene product, N-Tes."Cancer Res. 61. 8896-8902 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M., Kita D., Futami K., Yamashita J., Fujimoto N., Sato H., Okada Y.: "Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma."J Neurosurg. 94. 464-473 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kita D., Takino T., Nakada M., Takahashi T., Yamashita J., Sato H.: "Expression of dominant negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin a 5 expression in U251 glioma cell line."Cancer Res. 61. 7985-7991 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Misaki K., Nakada M., Hayashi Y., Tachibana O., Yamashita J., Ueda F., Suzuki M.: "Contrast-enhanced fluid-attenuated inversion-recovery MRI is useful to detect the CSF dissemination of glioblastoma."J Comput Assist Tomogr. 25. 953-956 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakada M: "The role of matrix metalloproteinase on glioma invasion"Frontiers in Bioscience. (in press).

    • Related Report
      2002 Annual Research Report
  • [Publications] Nakada M: "Suppression of membrane-type 1 matrix metalloproteinase(MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes"Cancer Research. 61. 8896-8902 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kita D: "Expression of dominant negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin α 5 expression in U251 glioma cell line"Cancer Research. 61. 7985-7991 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nakada M: "Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma"Journal of Neurosurgery. 94. 464-473 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Misaki K: "Contrast-enhanced fluid-attenuated inversion-recovery MRI is useful to detect the CSF dissemination of glioblastoma"Journal of Computer Assisted Tomography. 25. 953-956 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] 中田光俊: "MT1-MMP制御分子;N-Tesの同定とグリオーマ浸潤制御効果の解析"ポストシークエンス時代における脳腫瘍の研究と治療. 119-127 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Nakada M: "Suppression of membrane-type 1 matrix metalloproteinase(MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes"Cancer Research. 61. 8896-8902 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Kita D: "Expression of dominant negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin α5 expression in U251 glioma cell line"Cancer Research. 61. 7985-7991 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nakada M: "Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma"Journal of Neurosurgery. 94. 464-473 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Misaki K: "Contrast-enhanced fluid-attenuated inversion-recovery MRI is useful to detect the CSF dissemination of glioblastoma"Journal of Computer Assisted Tomography. 25. 953-956 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi